Ranjit S Bindra

23PUBLICATIONS
146CO-AUTHORS
Gene and molecular therapyHaematological tumoursMolecular targetsImmunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 29, 2026
Targeting O6-methylguanine-DNA Methyltransferase Deficiency in Preclinical Models of Extracranial Human Cancers with a Tumor-Selective DNA-Modifying Agent.

|Jul 17, 2026
Leveraging Homologous Recombination Deficiency via the Repositioned Prodrug CB1954.

|Jan 12, 2026
Targeted CRISPR knockout screening identifies known and novel chemogenomic interactions between DNA damaging agents and DNA repair genes.

Collin D Heer, James L Elia, Vijay Menon

|Jul 16, 2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer.

Elias Quijano, Diana Martinez-Saucedo, Zaira Ianniello

|Dec 10, 2024
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.

Matthew McCord, Thomas Sears, Wenxia Wang

|Jul 01, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion.

Katelyn J Noronha, Karlie N Lucas, Sateja Paradkar

Pageof 4

Frequent Collaborators

6 joint publications

Ranjini K Sundaram

5 joint publications

W Mark Saltzman

3 joint publications

Juan C Vasquez

3 joint publications

Hee-Won Suh